Summary & Overview
HCPCS Level II E0601: Continuous Positive Airway Pressure (CPAP) Device
HCPCS Level II code E0601 designates a continuous positive airway pressure (CPAP) device, a commonly prescribed durable medical equipment item for managing obstructive sleep apnea and related respiratory conditions in the outpatient/home setting. Nationally, CPAP devices are central to ambulatory respiratory care because they prevent airway collapse during sleep, reduce morbidity associated with untreated sleep-disordered breathing, and are widely used across payer types. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. Readers will find an overview of clinical context and typical usage, comparisons of payer coverage themes and common billing pathways, a concise listing of applicable billing modifiers and rental versus purchase distinctions, and references to clinically related device options that may be considered when E0601 is ineffective. The publication also summarizes relevant ICD-10 diagnosis alignment and notes where coverage language differentiates bi-level devices from CPAP. Benchmarks and policy updates are presented to clarify how coverage criteria and equipment categories affect billing and claims processing. Data not available in the input is explicitly identified where applicable. This summary is intended to orient clinicians, billing staff, and policy analysts to the operative coding, service context, and payer landscape for CPAP device billing under HCPCS Level II code E0601.
Billing Code Overview
HCPCS Level II code E0601 represents a continuous positive airway pressure (CPAP) device used as durable medical equipment for patients requiring respiratory assistance. This device provides a continuous flow of air pressure to maintain airway patency during sleep and is intended for use in a home (DMEPOS) setting. The service type is Durable medical equipment – Respiratory assist device.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with daytime sleepiness, loud snoring, and witnessed apneas undergoes an in-lab polysomnography confirming moderate-to-severe obstructive sleep apnea (OSA). The sleep medicine physician documents the diagnosis and a face-to-face evaluation supports the need for a home continuous positive airway pressure device for ongoing therapy. The durable medical equipment supplier arranges delivery of the HCPCS Level II code E0601 device to the patient’s home (DMEPOS setting). The typical clinical workflow includes: initial sleep study and diagnosis, physician order for E0601, DME supplier verification of coverage and rental or purchase status, delivery and setup in the home, patient education on device use, and follow-up to assess adherence and effectiveness.
Coding Specifications
-
Modifiers
-
NU- New Equipment: used when theE0601device is furnished to a patient who has not previously received this specific DME item as new equipment. -
RR- Rental: used when theE0601device is provided on a rental basis rather than purchased outright. -
KX- Requirements specified in the medical policy have been met: used when documentation meets payer-specific medical policy criteria for coverage ofE0601. -
Provider Taxonomies and Specialties
-
332B00000X- Durable Medical Equipment & Medical Supplies: represents DME suppliers and facilities that furnish equipment such asE0601. -
207RP1001X- Pulmonary Disease Physician: represents pulmonologists who diagnose and manage OSA and prescribe respiratory assist devices. -
207RC0200X- Critical Care Medicine Physician: represents critical care specialists who may be involved in complex respiratory failure cases; listed as an associated taxonomy for the device.
Related Diagnoses
-
G47.33- Obstructive sleep apnea (adult) (pediatric)- Clinical relevance:
G47.33is the diagnosis most commonly associated with prescribing HCPCS Level II codeE0601. The diagnosis indicates recurrent upper airway obstruction during sleep leading to oxygen desaturation and daytime symptoms; documentation ofG47.33supports medical necessity for a CPAP device.
- Clinical relevance:
Related Codes
-
E0470- Bi-level respiratory assist device without backup rate: used as an alternative whenE0601(CPAP) is ineffective for managing obstructive sleep apnea; may follow a trial ofE0601if clinical response is inadequate. -
E0471- Bi-level respiratory assist device with backup rate: listed as related but noted as not covered for primary OSA diagnosis; not typically used as a first-line device in standard OSA management.
These related HCPCS Level II codes are alternatives to E0601 in clinical workflows. E0470 is commonly considered when CPAP (E0601) fails to control symptoms or when higher-level ventilatory support is indicated. E0471 is an alternative device type but is restricted for primary OSA coverage in many policies.
National Reimbursement Benchmarks
The national mean for Medicare is not provided in the input and is listed as $0.00 for reference; BUCA (average commercial) reports a mean of $306.66, which is higher than the available commercial means for Aetna ($245.28) and Cigna Health ($260.11) but lower than UnitedHealthcare ($391.44). This places BUCA above several commercial payers but below the highest national commercial mean.
Rate dispersion (P75 minus P25) varies notably across payers. Blue Cross Blue Shield shows the widest spread at $305.20 (P75 $379.00 minus P25 $73.80), indicating substantial variation. UnitedHealthcare and Aetna have moderate dispersion at $123.75 and $95.61 respectively. Cigna Health is the tightest with no observed dispersion (P75, P50, P25 all $214.67). The table and chart below present the full breakdown of mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.